We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.80 | 3.60 | 4.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/7/2024 07:28 | How long lasting is the previous EUA for Italy ? Edit (8/7/24): EUA =120 days | money never sleeps | |
04/7/2024 06:20 | Also worth adding to the picture is this from Smith..Re Ecovelex @6.45m; and where Smith says 'possibly' consider the concrete nature of the 2021 prediction of a 2024 growing season . 'Possibly' Mr Smith.. Mr Costa's 'very soon' sounds far more likely ?? (AWGATWT) "We will be pursuing another EUA for 2025 growing season later this year particularly in Italy but possibly other territories across Europe so with that new product entering the market were very optimistic how 2024 will look" | supersonico | |
03/7/2024 18:00 | I share Investing's optimism for a full 2025 planting season Ecovelex EU approval based on Leonardo Costa's commentary at the seed federation event...keeping in mind the accuracy of the Corteva/Eden- 2024 planting season timetable of 2021. I would offer the @35min Abrey comment about peak sales being sooner for Ecovelex as supporting evidence of this possibility. | supersonico | |
03/7/2024 17:42 | For me, Market regulation activity will always be a thorn in Eden’s side and equally a path to the pot of gold at the end of the rainbow. The time it takes to get regulatory approval is ridiculously long, complex and time consuming and seems at least on the face of it, needs to be partially redone in every country Eden go after. (I know it’s the same for all players in this game). Equally however, the more the regulations ban plastic and toxic chemistry ultimately the better for Eden as it just opens up more and more opportunities. For me, Eden needs to absolutely get to break even and become cash generating so they can get more and more of these regulatory approvals and new opportunities running in parallel. At the moment it’s clear they are being cautious and selective in what they go for to stretch the funds they do have as far as they can. Ecovelux approval across EU cannot come soon enough for me, to get this euros rolling in. | kittybiscuits | |
03/7/2024 15:21 | Acquisition of Phyteurop SA distribution assets. Today marks a new milestone for Sipcam Oxon. We expand our operations by the acquisition of all distribution assets of Phyteurop SA through our newly established subsidiary, Sipcam France SA. We are proud of this acquisition. Phyteurop, founded in 1973 and headquartered in Paris, is part of the GROUPE INVIVO cooperative group. Sipcam France intends to maintain a strong partnership with InVivo to ensure continued access to a wide range of solutions for French agriculture, including traditional and innovative agrochemicals, fertilizers, biorational products, and biostimulants. | supersonico | |
03/7/2024 15:12 | I Wonder how or if Ecovelex will a part of these formulations with Corteva's other partners. Nashmin Ebrahimi Senior Research Scientist @Pro Farm Group Another field visit to France was a great opportunity to see the effects of what has been developed in the lab on plants in real conditions. Field visits always give me more information and a better overview of the next step in the development of biocontrol and biostimulant products. Being in Toulous and ProFarm Group collaboration with Corteva gave me a good opportunity to visit the Corteva Seed Applied Technologies (CSATs) and meet the CSATs team. The CSATs function as a laboratory, testing center and seed treatment facility with rigorous processes for the discovery, formulation and field testing of seed treatment technologies. This process allows seed treatments to be protected and improved to solve on-farm challenges and provide value to farmers. The PASSER tests in the CSATs are high quality and scientifically based to ensure that farmers get right products in their hands. | supersonico | |
03/7/2024 14:47 | Hahaha!! And also > Yes, it seems that the long march upwards has finally begun. THIRTY YEARS OF THE SAME REFRAIN - No Sales - No Profits - No Dividends BUT - Plenty of dilutions - Plenty of directors' troughs Apart from erinvale1, ravenna23 and myself, all other regulars here are either PAID RAMPING LIARS or DESPERATE TRAPPED BULLS, suffering Stockholm Syndrome, trying to engineer a spike so they can exit with something. FUTURE - Prepack with ZERO for the Ords. Get out while you can, buy Corteva if you must. They'll end up owning anything that just might be valuable in this toxic pile of poo. | neutralpov | |
03/7/2024 14:06 | I think number 3, MR, providing a runway to profit, will lead the way. | investingisatrickygame | |
03/7/2024 14:01 | The share price is lagging potential and I've been thinking more on the main five issues relating to that at the AGM so here using cut n paste from my AGM reflections .1- Call us when you're in profit.2 - Get to £100 million marcap3 - Market Regulation (AIM)4 - Regulators in our industry5 - Sellers in waiting Let's look at point 1.* Of all the points that might move us from slow classical Schubert to faster Eric Clapton is this not the one? Break even.What will the turnover have to be ?That's so easy to model I hardly need a spreadsheet.Turnover times Margin less Expenditure Equals Profit/lossI stress I am just modelling things here . Will we be able to see in the half year results any hints of Six Million turnover in 2024 giving us a contribution of say three to pronounce the end of loss making.? Or will opex creep up along with investment requiring turnover nearer say nine? | alchemy | |
03/7/2024 12:16 | Ps. Yes, I have read / viewed everything there is | money never sleeps | |
03/7/2024 11:31 | babysitter - I am certain they said it WAS doing just that in a recent interview / Eden broadcast. That must be right or else I would never have even formed the thought in the first place. MY VIEW is that we will therefore see the share price drop on results IF there is no EU authorisation for Ecovelex in H2 2024, which leaves me in a BIG quandry as to whether to commit more funds now or just simply wait for an even better buy in price. I am leaning towards the latter, but happy to be corrected. Though, you will see if you scour the recent news items I did not dream this up. | money never sleeps | |
03/7/2024 10:34 | MNS, I don't recognise the situation you suggest. Did you watch the recent Corteva interview and what they had to say about Ecovelex. If not, take a look. I think this might re-shape your view. | investingisatrickygame | |
03/7/2024 10:24 | Have specifically asked about this at the AGM. Product is NOT sitting in inventory. | babysitter | |
03/7/2024 10:01 | There is one big issue to come here, when judging the book by its accounts. Ecovelex. it brought a timely boost to revenues in late 2023. Nothing so far. Those sales are probably sitting in inventory, unsold, due to the 2024 wet weather growing season. Ecovelex is clearly a valuable product for the future and a good reason to invest here, but there are industry moves afoot to delay bans on existing harmful chemicals (e.g. the recent delay in the UK after lobbying pressure). Equally, there are efforts to speed through the new tech, like Ecovelex, so there will be a solution, so who knows what the short term future holds for this product in H2 2024 - but I can see reasons why revenue growth might take a pause, and that the share price might take a hit. Views? | money never sleeps | |
03/7/2024 09:32 | It looks to me like Eden is finally turning the corner commercially and that that will be well represented in their accounts. With a good wind, the share price will reflect this too. Let's talk about that and not NPOV. Time for you all to block his/her valueless posts and focus on your investment. | investingisatrickygame | |
03/7/2024 08:57 | Here comes the sun? | timbo_slice | |
03/7/2024 05:04 | Even a broken clock is right twice a day. Overall tho, it’s still useless. | kittybiscuits | |
02/7/2024 16:19 | POV posted 2,809 all on EDEN and no other shares. It's MENTEL sad really. | monet | |
02/7/2024 16:13 | Yes, it seems that the long march upwards has finally begun. | money never sleeps | |
02/7/2024 16:08 | POV, Someone who's been on here for years and has no shares spending all that time on here has MENTAL ILLNESS? Maybe that's where you are in a mental hospital, lots of time on your hands. That would explain a lot. | monet | |
02/7/2024 15:19 | Has anyone else noticed that investing here in any significant sum (i.e., greater than 5p) is associated causatively or exacerbatedly with profound and incurable MENTAL ILLNESS? :D | neutralpov | |
02/7/2024 15:16 | Has anyone else noticed all the big trades, most looked like buys at 0.045p or over, when mid price was 0,0435, from 26th June, about 4.9m shares. It's only gone up 0.20p | monet | |
02/7/2024 15:00 | Tour de France, Silverstone, Tennis, Soccer and modest rises . | alchemy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions